Ares Capital (ARCC) reported $732 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 4.4%. EPS of $0.50 for the same period compares to $0.59 a year ago.The reported revenue represents a surprise of -4.97% over the Zacks Consensus Estimate of $770.26 million. With the consensus EPS estimate being $0.54, the EPS surprise was -7.41%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...

In its upcoming report, Live Nation (LYV) is predicted by Wall Street analysts to post quarterly loss of $0.32 per share, reflecting an increase of 39.6% compared to the same period last year. Revenues are forecasted to be $3.49 billion, representing a year-over-year decrease of 8.3%.The consensus EPS estimate for the quarter has been revised 2.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during t ...

The upcoming report from Ameren (AEE) is expected to reveal quarterly earnings of $1.08 per share, indicating an increase of 10.2% compared to the year-ago period. Analysts forecast revenues of $1.98 billion, representing an increase of 9.2% year over year.The consensus EPS estimate for the quarter has been revised 15.8% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a c ...

Wall Street analysts expect AvalonBay Communities (AVB) to post quarterly earnings of $2.80 per share in its upcoming report, which indicates a year-over-year increase of 3.7%. Revenues are expected to be $747.26 million, up 4.8% from the year-ago quarter.Over the last 30 days, there has been a downward revision of 0.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of th ...

For the quarter ended March 2025, Northwest Bancshares (NWBI) reported revenue of $156.17 million, up 19% over the same period last year. EPS came in at $0.35, compared to $0.23 in the year-ago quarter.The reported revenue represents a surprise of +8.88% over the Zacks Consensus Estimate of $143.43 million. With the consensus EPS estimate being $0.25, the EPS surprise was +40.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...

Core Insights - COPT Defense reported revenue of $187.86 million for the quarter ended March 2025, a decrease of 2.8% year-over-year, with EPS at $0.65 compared to $0.29 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $185.72 million by 1.15%, while the EPS met the consensus estimate of $0.65 [1] Revenue Breakdown - Revenue from real estate operations was $177.60 million, surpassing the average estimate of $171.43 million, but reflecting an 8.1% decline year-over-year [4] - Revenue from construction contracts and other services was $10.26 million, significantly below the average estimate of $14.29 million, marking a 61.4% decrease year-over-year [4] Stock Performance - COPT Defense shares have returned -3.4% over the past month, compared to a -4.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Revvity (RVTY) reported revenue of $664.76 million for the quarter ended March 2025, reflecting a 2.3% increase year-over-year and a surprise of +0.39% over the Zacks Consensus Estimate of $662.17 million [1] - The company's EPS for the quarter was $1.01, up from $0.98 in the same quarter last year, resulting in an EPS surprise of +5.21% compared to the consensus estimate of $0.96 [1] Revenue and Earnings Performance - Organic revenue growth in Life Sciences was 2%, below the average estimate of 6.1% from three analysts [4] - Total organic revenue growth was reported at 4%, exceeding the average estimate of 3.6% from three analysts [4] - Organic revenue growth in Diagnostics was 5%, significantly higher than the average estimate of 1.5% from three analysts [4] Sales Metrics - Net Sales in Life Sciences reached $340.40 million, slightly above the average estimate of $338.13 million from three analysts, with a year-over-year change of +12.3% [4] - Net Sales in Diagnostics were reported at $324.37 million, slightly below the average estimate of $324.78 million from three analysts, representing a year-over-year decline of -6.6% [4] Stock Performance - Revvity's shares have returned -10.7% over the past month, compared to a -4.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Wall Street analysts expect Dominion Energy (D) to post quarterly earnings of $0.77 per share in its upcoming report, which indicates a year-over-year increase of 40%. Revenues are expected to be $3.85 billion, up 6% from the year-ago quarter. The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period. Before a company ...

The upcoming report from Cardinal Health (CAH) is expected to reveal quarterly earnings of $2.15 per share, indicating an increase of 3.4% compared to the year-ago period. Analysts forecast revenues of $55.03 billion, representing an increase of 0.2% year over year. Analysts forecast 'Segment profit- Pharmaceutical and Specialty Solutions' to reach $635.77 million. Compared to the present estimate, the company reported $580 million in the same quarter last year. Analysts predict that the 'Segment profit- Gl ...

Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock. While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, ...